Illumina, Inc. Logo

Illumina, Inc.

ILMN

(1.0)
Stock Price

136,02 USD

-64.44% ROA

-42.15% ROE

-7.29x PER

Market Cap.

22.247.838.000,00 USD

160.52% DER

0% Yield

-36.1% NPM

Illumina, Inc. Stock Analysis

Illumina, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Illumina, Inc. Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a low debt to equity ratio (45%), which means it has a small amount of debt compared to the ownership it holds

2 PBV

The stock's PBV ratio (2.27x) reflects a fair valuation, making it an attractive option for investors seeking balanced opportunities.

3 Graham Number

The Graham number calculation reveals that this company's stock price is potentially underestimated, implying that it may be a promising investment option.

4 ROE

The stock's ROE indicates a negative return (-63.01%) on shareholders' equity, suggesting poor financial performance.

5 ROA

The stock's ROA (-78.31%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

6 Revenue Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

7 Net Profit Growth

Over the past five years, this company's net profit has failed to exhibit any growth, indicating a stagnant financial performance and making it a less favorable choice for potential investors.

8 Assets Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

9 Dividend Growth

The company's dividend growth has been flat for the past three years, raising concerns for potential investors seeking reliable returns.

10 Dividend

Investors should be cautious as the company hasn't distributed dividends in the last three years, possibly indicating financial challenges.

11 Buffet Intrinsic Value

The company's stock appears overvalued (89) by Warren Buffett's formula, suggesting a less favorable investment opportunity as its market price exceeds its estimated intrinsic value.

Illumina, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Illumina, Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Sell
4 Stoch RSI Sell

Illumina, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Illumina, Inc. Revenue
Year Revenue Growth
1999 474.026
2000 1.309.111 63.79%
2001 2.486.000 47.34%
2002 10.040.000 75.24%
2003 28.035.000 64.19%
2004 50.583.000 44.58%
2005 73.501.000 31.18%
2006 184.586.000 60.18%
2007 366.799.000 49.68%
2008 573.225.000 36.01%
2009 666.324.000 13.97%
2010 902.741.000 26.19%
2011 1.055.535.000 14.48%
2012 1.148.516.000 8.1%
2013 1.421.178.000 19.19%
2014 1.861.358.000 23.65%
2015 2.219.762.000 16.15%
2016 2.398.373.000 7.45%
2017 2.752.000.000 12.85%
2018 3.333.000.000 17.43%
2019 3.543.000.000 5.93%
2020 3.239.000.000 -9.39%
2021 4.526.000.000 28.44%
2022 4.584.000.000 1.27%
2023 4.476.000.000 -2.41%
2023 4.504.000.000 0.62%
2024 4.448.000.000 -1.26%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Illumina, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
1999 4.085.743
2000 13.554.365 69.86%
2001 20.735.000 34.63%
2002 26.848.000 22.77%
2003 22.511.000 -19.27%
2004 21.114.000 -6.62%
2005 27.725.000 23.84%
2006 33.373.000 16.92%
2007 73.943.000 54.87%
2008 99.963.000 26.03%
2009 140.616.000 28.91%
2010 177.947.000 20.98%
2011 196.913.000 9.63%
2012 231.025.000 14.77%
2013 276.743.000 16.52%
2014 388.055.000 28.68%
2015 401.527.000 3.36%
2016 504.415.000 20.4%
2017 546.000.000 7.62%
2018 623.000.000 12.36%
2019 647.000.000 3.71%
2020 682.000.000 5.13%
2021 1.185.000.000 42.45%
2022 1.321.000.000 10.3%
2023 1.260.000.000 -4.84%
2023 1.330.000.000 5.26%
2024 1.300.000.000 -2.31%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Illumina, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
1999 0
2000 0 0%
2001 5.663.000 100%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 23.136.000 100%
2013 13.621.000 -69.86%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Illumina, Inc. EBITDA
Year EBITDA Growth
1999 -4.864.220
2000 -16.040.122 69.67%
2001 -22.556.000 28.89%
2002 -24.303.000 7.19%
2003 -18.435.000 -31.83%
2004 -4.716.000 -290.9%
2005 14.150.000 133.33%
2006 43.520.000 67.49%
2007 375.950.000 88.42%
2008 162.773.000 -130.97%
2009 154.927.000 -5.06%
2010 237.929.000 34.89%
2011 283.987.000 16.22%
2012 312.272.000 9.06%
2013 374.101.000 16.53%
2014 372.033.000 -0.56%
2015 633.371.000 41.26%
2016 571.024.000 -10.92%
2017 606.000.000 5.77%
2018 883.000.000 31.37%
2019 985.000.000 10.36%
2020 580.000.000 -69.83%
2021 -123.000.000 571.54%
2022 4.887.000.000 102.52%
2023 3.544.000.000 -37.9%
2023 362.000.000 -879.01%
2024 2.356.000.000 84.63%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Illumina, Inc. Gross Profit
Year Gross Profit Growth
1999 570.393
2000 1.707.274 66.59%
2001 1.929.000 11.49%
2002 6.504.000 70.34%
2003 17.998.000 63.86%
2004 37.324.000 51.78%
2005 50.320.000 25.83%
2006 125.242.000 59.82%
2007 234.363.000 46.56%
2008 367.601.000 36.25%
2009 460.555.000 20.18%
2010 601.540.000 23.44%
2011 709.098.000 15.17%
2012 773.528.000 8.33%
2013 911.887.000 15.17%
2014 1.297.710.000 29.73%
2015 1.549.290.000 16.24%
2016 1.666.448.000 7.03%
2017 1.826.000.000 8.74%
2018 2.300.000.000 20.61%
2019 2.467.000.000 6.77%
2020 2.203.000.000 -11.98%
2021 3.154.000.000 30.15%
2022 2.972.000.000 -6.12%
2023 2.736.000.000 -8.63%
2023 2.750.000.000 0.51%
2024 2.884.000.000 4.65%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Illumina, Inc. Net Profit
Year Net Profit Growth
1999 -5.517.645
2000 -18.606.465 70.35%
2001 -24.823.000 25.04%
2002 -40.331.000 38.45%
2003 -27.063.000 -49.03%
2004 -6.225.000 -334.75%
2005 -20.874.000 70.18%
2006 39.968.000 152.23%
2007 -278.359.000 114.36%
2008 50.477.000 651.46%
2009 72.281.000 30.17%
2010 124.891.000 42.12%
2011 86.628.000 -44.17%
2012 151.254.000 42.73%
2013 125.308.000 -20.71%
2014 353.351.000 64.54%
2015 461.559.000 23.44%
2016 462.649.000 0.24%
2017 726.000.000 36.27%
2018 826.000.000 12.11%
2019 1.002.000.000 17.56%
2020 656.000.000 -52.74%
2021 762.000.000 13.91%
2022 -4.404.000.000 117.3%
2023 -3.016.000.000 -46.02%
2023 -1.161.000.000 -159.78%
2024 -7.952.000.000 85.4%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Illumina, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1999 -2
2000 -1 0%
2001 0 0%
2002 -1 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 -3 100%
2008 0 0%
2009 1 0%
2010 1 100%
2011 1 0%
2012 1 100%
2013 1 0%
2014 3 50%
2015 3 33.33%
2016 3 0%
2017 5 25%
2018 6 20%
2019 7 16.67%
2020 4 -50%
2021 5 20%
2022 -28 117.86%
2023 -19 -47.37%
2023 -7 -171.43%
2024 -50 86%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Illumina, Inc. Free Cashflow
Year Free Cashflow Growth
1999 -3.202.416
2000 -17.739.408 81.95%
2001 -25.897.000 31.5%
2002 -52.423.000 50.6%
2003 -20.288.000 -158.39%
2004 -22.929.000 11.52%
2005 -20.403.000 -12.38%
2006 23.786.000 185.78%
2007 31.866.000 25.36%
2008 -7.811.000 507.96%
2009 119.274.000 106.55%
2010 216.105.000 44.81%
2011 278.590.000 22.43%
2012 210.864.000 -32.12%
2013 295.862.000 28.73%
2014 359.055.000 17.6%
2015 516.349.000 30.46%
2016 415.857.000 -24.17%
2017 563.000.000 26.14%
2018 846.000.000 33.45%
2019 842.000.000 -0.48%
2020 891.000.000 5.5%
2021 337.000.000 -164.39%
2022 -74.000.000 555.41%
2023 94.000.000 178.72%
2023 281.000.000 66.55%
2024 49.000.000 -473.47%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Illumina, Inc. Operating Cashflow
Year Operating Cashflow Growth
1999 -2.907.130
2000 -14.311.351 79.69%
2001 -10.925.000 -31%
2002 -25.593.000 57.31%
2003 -18.256.000 -40.19%
2004 -19.574.000 6.73%
2005 -9.008.000 -117.3%
2006 39.000.000 123.1%
2007 56.294.000 30.72%
2008 87.882.000 35.94%
2009 174.496.000 49.64%
2010 272.573.000 35.98%
2011 358.140.000 23.89%
2012 291.873.000 -22.7%
2013 386.421.000 24.47%
2014 501.271.000 22.91%
2015 659.596.000 24%
2016 687.238.000 4.02%
2017 875.000.000 21.46%
2018 1.142.000.000 23.38%
2019 1.051.000.000 -8.66%
2020 1.080.000.000 2.69%
2021 545.000.000 -98.17%
2022 392.000.000 -39.03%
2023 139.000.000 -182.01%
2023 477.000.000 70.86%
2024 80.000.000 -496.25%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Illumina, Inc. Capital Expenditure
Year Capital Expenditure Growth
1999 295.286
2000 3.428.057 91.39%
2001 14.972.000 77.1%
2002 26.830.000 44.2%
2003 2.032.000 -1220.37%
2004 3.355.000 39.43%
2005 11.395.000 70.56%
2006 15.214.000 25.1%
2007 24.428.000 37.72%
2008 95.693.000 74.47%
2009 55.222.000 -73.29%
2010 56.468.000 2.21%
2011 79.550.000 29.02%
2012 81.009.000 1.8%
2013 90.559.000 10.55%
2014 142.216.000 36.32%
2015 143.247.000 0.72%
2016 271.381.000 47.22%
2017 312.000.000 13.02%
2018 296.000.000 -5.41%
2019 209.000.000 -41.63%
2020 189.000.000 -10.58%
2021 208.000.000 9.13%
2022 466.000.000 55.36%
2023 45.000.000 -935.56%
2023 196.000.000 77.04%
2024 31.000.000 -532.26%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Illumina, Inc. Equity
Year Equity Growth
1999 32.032.250
2000 124.099.736 74.19%
2001 106.791.000 -16.21%
2002 71.744.000 -48.85%
2003 47.388.000 -51.4%
2004 72.262.000 34.42%
2005 72.497.000 0.32%
2006 247.342.000 70.69%
2007 411.678.000 39.92%
2008 848.596.000 51.49%
2009 864.248.000 1.81%
2010 1.197.675.000 27.84%
2011 1.075.215.000 -11.39%
2012 1.318.581.000 18.46%
2013 1.533.202.000 14%
2014 1.462.798.000 -4.81%
2015 1.881.099.000 22.24%
2016 2.343.241.000 19.72%
2017 3.064.000.000 23.52%
2018 3.932.000.000 22.08%
2019 4.613.000.000 14.76%
2020 4.694.000.000 1.73%
2021 10.740.000.000 56.29%
2022 6.599.000.000 -62.75%
2023 5.745.000.000 -14.87%
2023 5.898.000.000 2.59%
2024 1.436.000.000 -310.72%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Illumina, Inc. Assets
Year Assets Growth
1999 33.894.658
2000 132.792.679 74.48%
2001 122.465.000 -8.43%
2002 121.906.000 -0.46%
2003 99.234.000 -22.85%
2004 94.907.000 -4.56%
2005 100.610.000 5.67%
2006 300.584.000 66.53%
2007 987.732.000 69.57%
2008 1.377.100.000 28.27%
2009 1.429.937.000 3.7%
2010 1.839.113.000 22.25%
2011 2.195.840.000 16.25%
2012 2.566.085.000 14.43%
2013 3.019.006.000 15%
2014 3.337.440.000 9.54%
2015 3.687.747.000 9.5%
2016 4.280.600.000 13.85%
2017 5.257.000.000 18.57%
2018 6.959.000.000 24.46%
2019 7.316.000.000 4.88%
2020 7.585.000.000 3.55%
2021 15.217.000.000 50.15%
2022 12.252.000.000 -24.2%
2023 10.111.000.000 -21.17%
2023 10.122.000.000 0.11%
2024 6.081.000.000 -66.45%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Illumina, Inc. Liabilities
Year Liabilities Growth
1999 1.862.408
2000 8.692.943 78.58%
2001 15.674.000 44.54%
2002 50.162.000 68.75%
2003 51.846.000 3.25%
2004 22.645.000 -128.95%
2005 28.113.000 19.45%
2006 53.242.000 47.2%
2007 576.054.000 90.76%
2008 528.504.000 -9%
2009 565.689.000 6.57%
2010 641.438.000 11.81%
2011 1.120.625.000 42.76%
2012 1.247.504.000 10.17%
2013 1.485.804.000 16.04%
2014 1.874.642.000 20.74%
2015 1.839.194.000 -1.93%
2016 2.010.365.000 8.51%
2017 2.413.000.000 16.69%
2018 3.114.000.000 22.51%
2019 2.703.000.000 -15.21%
2020 2.891.000.000 6.5%
2021 4.477.000.000 35.43%
2022 5.653.000.000 20.8%
2023 4.366.000.000 -29.48%
2023 4.224.000.000 -3.36%
2024 4.645.000.000 9.06%

Illumina, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
27.86
Net Income per Share
-19.14
Price to Earning Ratio
-7.29x
Price To Sales Ratio
5.02x
POCF Ratio
42.79
PFCF Ratio
62.49
Price to Book Ratio
15.46
EV to Sales
5.48
EV Over EBITDA
15.41
EV to Operating CashFlow
46.72
EV to FreeCashFlow
68.11
Earnings Yield
-0.14
FreeCashFlow Yield
0.02
Market Cap
22,25 Bil.
Enterprise Value
24,25 Bil.
Graham Number
62.37
Graham NetNet
-18.1

Income Statement Metrics

Net Income per Share
-19.14
Income Quality
-0.08
ROE
-0.65
Return On Assets
-0.26
Return On Capital Employed
0.22
Net Income per EBT
1.03
EBT Per Ebit
-1.38
Ebit per Revenue
0.25
Effective Tax Rate
-0.03

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0.3
Stock Based Compensation to Revenue
0.09
Gross Profit Margin
0.64
Operating Profit Margin
0.25
Pretax Profit Margin
-0.35
Net Profit Margin
-0.36

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
3.26
Free CashFlow per Share
2.24
Capex to Operating CashFlow
0.31
Capex to Revenue
0.04
Capex to Depreciation
0.38
Return on Invested Capital
-0.1
Return on Tangible Assets
-0.64
Days Sales Outstanding
54.14
Days Payables Outstanding
43.18
Days of Inventory on Hand
121.74
Receivables Turnover
6.74
Payables Turnover
8.45
Inventory Turnover
3
Capex per Share
1.03

Balance Sheet

Cash per Share
6,25
Book Value per Share
9,03
Tangible Book Value per Share
0.5
Shareholders Equity per Share
9.03
Interest Debt per Share
14.73
Debt to Equity
1.61
Debt to Assets
0.38
Net Debt to EBITDA
1.27
Current Ratio
1.11
Tangible Asset Value
0,08 Bil.
Net Current Asset Value
-2,19 Bil.
Invested Capital
2927000000
Working Capital
0,25 Bil.
Intangibles to Total Assets
0.22
Average Receivables
0,65 Bil.
Average Payables
0,20 Bil.
Average Inventory
572500000
Debt to Market Cap
0.1

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Illumina, Inc. Dividends
Year Dividends Growth

Illumina, Inc. Profile

About Illumina, Inc.

Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements, as well as cancer detection testing services. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. The company was incorporated in 1998 and is based in San Diego, California.

CEO
Mr. Jacob Thaysen Ph.D.
Employee
10.590
Address
5200 Illumina Way
San Diego, 92122

Illumina, Inc. Executives & BODs

Illumina, Inc. Executives & BODs
# Name Age
1 Ms. Carissa L. Rollins
Chief Information Officer
70
2 Mr. Scott Davies
Interim General Counsel & Secretary
70
3 Mr. Charles E. Dadswell Esq.
Advisor
70
4 Mr. Kevin Carl Pegels
Chief of Global Operations
70
5 Mr. Scott Ericksen
Vice President & Chief Accounting Officer
70
6 Dr. Steven Barnard Ph.D.
Chief Technology Officer
70
7 Ms. Sallilyn Schwartz
Vice President of Investor Relations
70
8 Mr. Jakob Wedel
Chief Strategy & Corporate Development Officer and Chief Executive Officer Chief of Staff
70
9 Stephanie Campos
President
70
10 Mr. Jacob Thaysen Ph.D.
Chief Executive Officer & Director
70

Illumina, Inc. Competitors